MedTrace Logo

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

NCT00599521 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1067

Last updated 2021-02-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Adapalene lotion 0.1%

Adapalene, 0.1% will be applied topically to the face, once a day, for 12 weeks

DRUG

Adapalene Lotion Vehicle

Vehicle will be applied topically to the face, once a day, for 12 weeks

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-11-30
Completion
2008-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00599521 on ClinicalTrials.gov